Drug-Coated Balloons for Treatment of Carotid In-Stent Restenosis: Did We Find the Ace of Hearts?

Lal BK Hobson RW Goldstein J . In-stent recurrent stenosis after carotid stenting: life table analysis and clinical relevance. J Vasc Surg. 2003;38:1162–1169.

Chakhtoura EY Hobson RW Goldstein J . In-stent restenosis after carotid angioplasty-stenting: incidence and management. J Vasc Surg. 2001;33:220–226.

Lal BK . Recurrent carotid stenosis after CEA and CAS: diagnosis and management. Semin Vasc Surg. 2007;20:259–266.

Setacci C Chisci E Setacci F . Grading carotid intrastent restenosis: a 6-year follow-up study. Stroke. 2008;39:1189–1196.

Donas KP Eisenack M Torsello G . Balloon angioplasty for in-stent stenosis after carotid artery stenting is associated with an increase in repeat interventions. J Endovasc Ther. 2011;18:720–725.

van Haaften AC Bots ML Moll FL . Therapeutic options for carotid in-stent restenosis: review of the literature. J Vasc Interv Radiol. 2010;21:1471–1477.

Bendok BR Roubin GS Katzen BT . Cutting balloon to treat carotid in-stent stenosis: technical note. J Invasive Cardiol. 2003;15:227–232.

Zhou W Lin PH Bush RL . Management of in-stent restenosis after carotid artery stenting in high-risk patients. J Vasc Surg. 2006;43:305–312.

Reimers B Tübler T de Donato G . Endovascular treatment of in-stent restenosis after carotid artery stenting: immediate and midterm results. J Endovasc Ther. 2006;13:429–435.

Gonzales A Drummond M McCord S . Carotid endarterectomy for treatment of in-stent restenosis. J Vasc Surg. 2011;54:1167–1169.

Tekieli L Pieniazek P Musialek P . Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population. J Endovasc Ther. 2012;19:316–324.

Loh JP Barbash IM Waksman R . The current status of drug-coated balloons in percutaneous coronary and peripheral interventions. EuroIntervention. 2013;9:979–988.

Montorsi P Galli S Ravagnani PM . Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report. J Endovasc Ther. 2012;19:734–742.

Liistro F Porto I Grotti S . Drug-eluting balloon angioplasty for carotid in-stent restenosis. J Endovasc Ther. 2012;19:729–733.

Gandini R Del Giudice C Da Ros V . Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis. J Endovasc Ther. 2014;21:671–677.

Bondesson P Lagerqvist B James SK . Comparison of two drug-eluting balloons: a report from the SCAAR registry. EuroIntervention. 2012;8:444–449.

Cassese S Kastrati A . Not all drug-eluting balloons are equally good for patients, not all patients are equally suitable for drug-eluting balloons. EuroIntervention. 2012;8:417–421.

Stabile E Virga V Salemme L . Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol. 2012;60:1793–1742.

Cremers B Clever Y Schaffer S . Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Minerva Cardioangiol. 2010;58:583–588.

Virga V Stabile E Biamino G . Drug-eluting balloon for the treatment of the superficial femoral artery in-stent restenosis. 2-year follow-up. JACC Cardiovasc Interv. 2014;7:411–415.

Liistro F Angioli P Porto I . Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther. 2014;21:1–8.

Stella PR Belkacemi A Waksman R . The Valentine trial: results of the first one week worldwide multicenter enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention. 2011;7:705–710.

Loh JP Sangiorgi G Silber S . Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: sub-analysis results from the Valentine I trial. Cardiovasc Rev Med. 2014;15:23–28.

Vajda Z Guthe T Perez MA . Prevention of intracranial restenosis: predilation with a drug eluting balloon, followed by the developing of a self-expanding stent. Cardiovasc Intervent Radiol. 2013;36:346–352.

Kleber FX Mathey D Rittger H . How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention. 2011;7: Suppl K:K125–128.

Orbach DB Pramanik BK Lee JL . Carotid artery stent implantation: evaluation with multidetector row CT angiography and virtual angioscopy-Initial experience. Radiology. 2006;238:309–320.

Nolz R Wibmer A Beitzke D . Carotid artery stenting and follow-up: value of 64-MSCT angiography as complementary imaging method to color-coded duplex sonography. Eur Radiol. 2012;81:89–94.

Lettau M Sauer A Heiland S . Carotid artery stents: in vitro comparison of different stent designs and sizes using CT angiography and contrast-enhanced MR angiography at 1.5T and 3T. AJNR Am J Neuroradiol. 2009;30:1993–1997.